BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2019 9:57:12 AM | Browse: 1089 | Download: 1320
 |
Received |
|
2018-10-30 07:48 |
|
Peer-Review Started |
|
2018-11-01 01:15 |
|
To Make the First Decision |
|
2018-11-29 09:28 |
|
Return for Revision |
|
2018-12-17 07:18 |
|
Revised |
|
2019-01-10 02:38 |
|
Second Decision |
|
2019-01-14 09:05 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-01-15 01:43 |
|
Articles in Press |
|
2019-01-15 01:43 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-02-13 09:38 |
|
Publish the Manuscript Online |
|
2019-02-14 09:57 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Brian M Fung, Keith D Lindor and James H Tabibian |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
James H Tabibian, MD, PhD, Health Sciences Clinical Associate Professor, David Geffen School of Medicine at UCLA, Director of Endoscopy, Olive View-UCLA Medical Center, 14445 Olive View Drive, 2B-182,, Sylmar, CA 91342, United States. jtabibian@dhs.lacounty.gov |
| Key Words |
Bile duct diseases; Cholangiocarcinoma; Gallbladder carcinoma; Hepatocellular carcinoma; Colorectal cancer; Chemoprotection; Inflammatory bowel disease |
| Core Tip |
Primary sclerosing cholangitis is a rare cholestatic liver disease characterized by progressive fibroinflammatory destruction of the bile ducts. It is associated with a significantly increased risk of malignancy over the general population, with nearly 50% of deaths in patients with primary sclerosing cholangitis caused by cancer, thus necessitating robust surveillance strategies. In this article, we provide a synopsis of the epidemiology, prevention, and surveillance of cancers in patients with primary sclerosing cholangitis. |
| Publish Date |
2019-02-14 09:57 |
| Citation |
Fung BM, Lindor KD, Tabibian JH. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. World J Gastroenterol 2019; 25(6): 659-671 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i6/659.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i6.659 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
